Nicholas K. Akers - Concepedia

Concepedia

Author

Nicholas K. Akers

Icahn School of Medicine at Mount Sinai ORCID

Also Known As

Akers, Nicholas, Bhardwaj, Nina, N K Akers, N. Akers, N. K. Akers, Nicholas Akers, Nicholas K Akers, Nicholas K. Akers, Nicholas K. Akers

55

Publications

2.5K

Citations

14

H-Index

37

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai University of California, Berkeley University of California, San Francisco Institució Catalana de Recerca i Estudis Avançats Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

NK

About

Nicholas K. Akers is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, immunology, and genetic epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.7K
2	Health Sciences	1	1	113
3	Public Health	1	1	310
4	Epidemiology	1	1	310
5	Hepatology	1	1	1K

Nicholas K. Akers

×

15

Publications

2.5K

Citations

14

H-Index

	Year	Citations
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features Daniela Sia, Yang Jiao, Iris Martinez-Quetglas, Gastroenterology HepatologyImmune-specific ClassImmunologyHistopathologyHepatitis	2017	1K
Intratumoral heterogeneity and clonal evolution in liver cancer Bojan Losic, Amanda J. Craig, Carlos Villacorta-Martín, Nature Communications	2020	342
Cardiometabolic risk loci share downstream cis- and trans-gene regulation across tissues and diseases Oscar Franzén, Raili Ermel, Ariella Cohain, Science Abdominal FatCardiometabolic RiskTrans-gene RegulationGeneticsRisk Loci	2016	310
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32 Lucía Conde, Eran Halperin, Nicholas K. Akers, Nature Genetics Genome-wide Association StudyLymphoid NeoplasiaCancer PathologyRisk LocusMedicine	2010	156
Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications Juan Carrillo-Reixach, Laura Torrens, Marina Simon‐Coma, Journal of Hepatology	2020	138
Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma Travers Ching, Megan E. Duncan, Tera Newman-Eerkes, BMC Cancer	2020	126
Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes Matthew D. Galsky, Huan Wang, Noah M. Hahn, European Urology Metastatic Urothelial CancerUrologyGenitourinary CancerMedicineClinical Trials	2017	113
Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region Christine F. Skibola, Sonja I. Berndt, Joseph Vijai, The American Journal of Human Genetics Genome-wide Association StudyLymphoid NeoplasiaImmunogeneticsGeneticsImmunology	2014	107
Associations between arsenic (+3 oxidation state) methyltransferase (<i>AS3MT</i>) and N‐6 adenine‐specific DNA methyltransferase 1 (<i>N6AMT1</i>) polymorphisms, arsenic metabolism, and cancer risk in a chilean population Rosemarie de la Rosa, Craig Steinmaus, Nicholas K. Akers, Environmental and Molecular Mutagenesis	2017	43
Multi‐locus HLA class I and II allele and haplotype associations with follicular lymphoma Christine F. Skibola, Nicholas K. Akers, Lucía Conde, Tissue Antigens	2012	31

Page 1